Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohort
Kevin M. Flanigan(Nationwide Children's Hospital), Robert B. Weiss(University of Utah), Līvija Medne(Children's Hospital of Philadelphia), Jacinda B. Sampson(University of Alabama at Birmingham), Alan Pestronk(Washington University in St. Louis), Payam Soltanzadeh(University of Utah), Andrew von Niederhausern(University of Utah), Marcia K. Margolis(University of Minnesota), Eduard Gappmaier(University of Utah), Brenda Wong(Cincinnati Children's Hospital Medical Center), Michael Howard(University of Utah), Katherine D. Mathews(University of Iowa), P. Morehart(Cincinnati Children's Hospital Medical Center), Veronica J. Hinton(NewYork–Presbyterian Hospital), Amy Meyer(Cincinnati Children's Hospital Medical Center), Carrie Stephan(University of Iowa), Cheryl Wall(Nationwide Children's Hospital), Richard S. Finkel(St. Jude Children's Research Hospital), Anne M. Connolly(Washington University in St. Louis), Jerry R. Mendell(Nationwide Children's Hospital), Carsten G. Bönnemann(Children's Hospital of Philadelphia), Julaine Florence, Diane M. Dunn(University of Utah), Joline Dalton(University of Minnesota), Wendy King(The Ohio State University), Karla S. Laubenthal(University of Iowa)
Cited by 314
Related Papers
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management
|The Lancet Neurology|2009|2k
Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care
|The Lancet Neurology|2009|1.2k
Evidence‐based path to newborn screening for duchenne muscular dystrophy
|Annals of Neurology|2012|816
Eteplirsen for the treatment of Duchenne muscular dystrophy
|Annals of Neurology|2013|793